The aim of this meta-analysis is to provide a comprehensive and updated evaluation of the association between blood levels of ICAM-1 and OSA while exploring the broader implications of ICAM-1 in CVD among OSA patients. The gene discussed is ICAM1; the disease is obstructive sleep apnea syndrome.